Interview with CEO Steen Klysner in Erhverv Nordsjælland
Expres2ion Biotechnologies is mentioned in the Danish newspaper Erhverv Nordsjælland. The article includes an interview with CEO Sten Klysner. The […]
ExpreS2ion’s Chief Scientific Officer, Dr. Wian de Jongh, to Speak at ISBiotech 7th Spring Meeting in Washington D.C. – March 6-8
Horsholm, Denmark, February 16, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, […]
ExpreS2ion’s Chief Scientific Officer, Dr. Wian de Jongh, is Appointed Affiliated Associate Professor at the Technical University of Denmark
Horsholm, Denmark, February 14, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, […]
Renewal of license agreement between ExpreS2ion Biotechnologies and the Francis Crick Institute
On August 23 2016 ExpreS2ion Biotechnologies ApS, Horsholm, Denmark (”ExpreS2ion”) and the Francis Crick Institute, London, United Kingdom, announce that […]
The ExpreS2 system is used for production of full-length soluble Plasmodium falciparum RH5 protein vaccine
The article “Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line […]
ExpreS2ion Biotechnologies contributes to scientific article
ExpreS2ion Biotechnologies’ scientists contributed to the research for the article by Thrane et al, ”Bacterial superglue enables easy development of […]
Dr Wian de Jongh, ExpreS2ion’s CSO will present at the “New Technologies, New Vaccines” conference being held March 20-23rd, 2016 in Wilmington, DE, USA
The talk titled “Development of Drosophilia S2 based sub-unit antigen vaccine production processes” will be held on Day 1 (Monday, […]
ExpreS2ion Bio’s CSO Dr Wian de Jongh to speak at the ISBiotech 6th Spring Meeting in Washington D.C. – March 7-9
The meeting features the most exciting and challenging discussions on the industry’s most difficult applications including viral gene vectors and […]
The contribution of ExpreS2ion is cited in this issue of the journal “Vaccine”, which reviews the status on Malaria vaccine development.
Edited by Robert W. Sauerwein and Thomas L. Richie Access the journal issue here: http://www.sciencedirect.com/science/journal/0264410X/33/52 Articles citing the use of ExpreS2: […]
ExpreS2ion will be present at the following events in November
BioEurope 2015 November 2–4, 2015, Munich, Germany http://www.ebdgroup.com/bioeurope/media/about_conf.php Is your project being slowed down by protein manufacturing challenges? Try ExpreS2, […]